Analysis of Mutations in the Gene Encoding Cytomegalovirus DNA Polymerase in a Phase 2 Clinical Trial of Brincidofovir Prophylaxis

Brincidofovir is an oral antiviral in development for prevention of cytomegalovirus disease. Cytomegalovirus genotyping results from a phase 2 trial comparing brincidofovir to placebo for prophylaxis against cytomegalovirus infection in hematopoietic cell transplant recipients provided initial data...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanier, E. Randall, Foster, Scott, Brundage, Tom, Chou, Sunwen, Prichard, Mark N., Kleiboeker, Steven, Wilson, Chad, Colville, Donella, Mommeja-Marin, Herve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907407/
https://www.ncbi.nlm.nih.gov/pubmed/26941282
http://dx.doi.org/10.1093/infdis/jiw073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907407/
https://www.ncbi.nlm.nih.gov/pubmed/26941282
http://dx.doi.org/10.1093/infdis/jiw073

Ejemplares similares